Therefore, a decrease in HS and HSPGs in pancreatic β-cells in DM leads to β-cell dysfunction, suggesting that inhibiting heparanase activity may protect pancreatic β-cell HS and thus inhibit DM progression. Here, HPSE is linked to diabetes mellitus.